Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Genexine, Inc.

Clinical trials sponsored by Genexine, Inc., explained in plain language.

Genexine, Inc. 095700 KOSDAQ

A South Korean biotech company developing immunotherapies and vaccines for cancer and infectious diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New anemia drug for dialysis patients enters final testing phase

Disease control Recruiting now

This study tests a new drug called efepoetin alfa for treating anemia in adults with advanced chronic kidney disease who are on dialysis. About 429 participants will receive either the new drug or an existing one to compare safety and effectiveness. The main goal is to see if the…

Phase: PHASE3 • Sponsor: Genexine, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC